The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale - Test2 - elhamkhani - TriplyDB

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

http://www.wikidata.org/entity/Q33696003

about

The evolving role of response-adapted PET imaging in Hodgkin lymphoma Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma Hodgkin lymphoma, version 2.2015.Advanced hodgkin lymphoma: a new era of therapy.Pulmonary actinomycosis and Hodgkin's disease: when FDG-PET may be misleading.Hodgkin disease-an ever-evolving therapy.Positron Emission Tomography (PET) in Oncology How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma.HLA-G expression and role in advanced-stage classical Hodgkin lymphoma.Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.FDG-PET imaging in hematological malignancies CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.Should Response-Adapted Therapy Now Be the Standard of Care for Advanced Hodgkin's Lymphoma?Recent advances in Hodgkin lymphoma: interim PET and molecular-targeted therapy.FDG PET/CT imaging as a biomarker in lymphoma.Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis.Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.Risk-adapted strategies for the treatment of Hodgkin lymphoma.Recent treatment advances in Hodgkin lymphoma: a concise review.Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).Effect of chemotherapy alone with adult chemotherapy regimens on prognosis of children and adolescents with Hodgkin's disease.Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.The role of FDG-PET in Hodgkin lymphoma Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer.

P2860

Q26750993-5E232471-88F4-403F-BF8C-F4D7EE3E2F3F Q26801870-4432A012-D530-4327-837C-31925D713D35 Q26858893-720A68C6-2628-486E-92A3-AF906FC0AA01 Q30491972-9390B835-3C14-429C-87F2-CC3EFA715EA5 Q30769157-5570550C-F3F4-4B9D-BD44-047A5492362F Q34194160-C5F6F034-6227-49A0-8490-E526316A21CF Q34235971-06E3E481-3865-40B2-B99A-C4A44782C2F2 Q34463426-40A13736-9370-44AC-87FD-75C169E24412 Q34774840-5FF1EC8B-0D48-4C33-A2BF-AA52B28D9402 Q35103531-3C3A7E43-6840-4CA6-BB64-512455D91D12 Q36057936-4BFE8B37-742A-4992-8A71-9E50ACBF992B Q36673451-18470AC7-A3A0-430F-84BA-C3BB2E60F38F Q36691438-6E55D616-5A5A-415C-A01D-11D1FB59E7A7 Q36706850-B640A108-232D-496A-98B8-30DE56214318 Q36897012-4519382C-E3F7-49C3-8496-64CE4B974B89 Q36985532-D7472AFF-A290-4F13-8F15-084B8C149EA3 Q37067425-21EA9D87-1FEC-4076-B8F7-CAAEF9ABC02C Q37176540-B4967CEE-5FBF-4CED-8243-9F47E253275E Q37632114-0B070261-42E5-40E8-8B4F-3696B479E8E7 Q37639665-4A848E59-EA88-4228-B7C2-47D1DB5D20B8 Q37694536-D03C0B1A-E180-4109-B9D2-E9C025127593 Q38285627-34F6C437-F919-4E80-90A7-2A1D7E0B647C Q38312367-E6E01DF7-50B0-48D9-A3F1-DA8D1F022836 Q38337152-5A52A5ED-218F-47E7-84AC-4BF30DE1F1F9 Q38418605-68145306-4238-40C6-94D4-A359C3F447EE Q38549745-2A678FEF-D5B4-4A0A-A90D-091B539BDCBF Q38591137-7157147C-FA4A-4F5B-8AE1-3B89226F19C1 Q38755955-9FC066D6-BD34-4545-A721-C701F31B4E54 Q38815516-C66C3D9C-BEE0-4D18-AA33-7E2E80ACA305 Q38936273-99537451-F6EC-46CF-AFDE-CF4017940D94 Q39324849-58A7E8B1-2256-4D64-91C4-36B97832AEAF Q39720437-0F797598-CD28-48A3-8F99-5FFCC09A0764 Q40762228-3C8EEE6E-761C-4418-9DE5-6D2A0E642E80 Q41108261-6B1CA82D-6FD0-44B2-BE7E-D9DF6FDAC498 Q41378943-E2EC1335-C186-43B9-AB3B-FF24F62CEA59 Q41481956-DBFD2E08-C8C3-4A58-BBEA-37A2EC32C1A3 Q41691698-6C54CD54-7251-48C9-82D6-BFFD47DD1222 Q44792403-5695B977-F29A-455E-BD7F-F84995283F55 Q47852690-73246374-6E12-446C-B9A1-544FB2FD0206 Q48125466-A2608969-BB55-4D90-A8BE-9794672AD3D2

P2860

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

http://www.wikidata.org/entity/Q33696003

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

The predictive role of interim ...... the Deauville five-point scale

@ast

The predictive role of interim ...... the Deauville five-point scale

@en

type

label

The predictive role of interim ...... the Deauville five-point scale

@ast

The predictive role of interim ...... the Deauville five-point scale

@en

prefLabel

The predictive role of interim ...... the Deauville five-point scale

@ast

The predictive role of interim ...... the Deauville five-point scale

@en

P1433

Q33696003-2E44A842-87D4-453D-8F7F-641024DC19A4

P1476

Q33696003-22440CB9-DC67-41A8-B527-8583729C717D

P2093

Q33696003-3ED1CEAE-2C12-47BB-BC23-19A12409376D

Q33696003-44867CCA-B56B-42A1-9A63-BCC6D3B8F2D9

Q33696003-559B1264-D114-4860-8854-87C9D97F158B

Q33696003-62DE4F50-DAAF-4E04-82ED-FB38C337292F

Q33696003-701E020B-229A-4C99-AC30-D7F6BF6B3DB6

Q33696003-7B8B6A16-BA47-4818-A70C-C5EB1A45460B

Q33696003-842154CB-231F-45E5-AC53-36F183E57D47

Q33696003-86AEE38F-C04B-46D9-892A-577D4E1700EC

Q33696003-8F3D3DA0-04F4-4BD5-B611-F577C69BE1CC

Q33696003-95330939-2885-4345-9FCE-245FD0427996

P2860

Q33696003-0CE05155-F8BA-4DB0-8D4A-97D28F54FC7C

Q33696003-0F937EA0-4903-4D65-97EC-D79A2FEC33EA

Q33696003-11D81356-C5C2-4DFB-8364-65409C5A5220

Q33696003-15F193A1-7B9B-4208-817D-64CC7CB1426C

Q33696003-1B375F21-0C79-49C4-8426-89E986603397

Q33696003-3A683CA1-59A3-4454-AB6D-B08FFE57BA63

Q33696003-418861E4-2898-4CCF-B801-2616C9886358

Q33696003-47623D48-B522-4BB6-BD92-1BFFBC22D799

Q33696003-4A31A210-B49B-45F6-B35F-CA9CDF4D85F1

Q33696003-53EA5015-E2F6-46BA-BF30-3CC2CD43D88A

P304

Q33696003-25A396EC-9076-4970-BBB9-C08587E90D9B

P31

Q33696003-6865D231-BCD6-4340-8507-7D303EB391BE

P356

Q33696003-BFF49F24-3D79-4955-AB81-410BDB2BA2E9

P433

Q33696003-2DFE133E-7D1C-4764-BD02-869D6D56E5A3

P478

Q33696003-1C8E8A16-E95A-45A3-8943-1E7B3B0E2967

P50

Q33696003-1875D137-1496-4D22-B713-5A2ECBC36444

Q33696003-2A4541BB-4235-45C7-A6B9-D45F92BF6E13

Q33696003-5987311E-0336-495D-8942-8CFCAE2B1B7A

Q33696003-73ED3FE3-F98C-4DE5-BAC5-68E01130DF1D

Q33696003-B2CCAFCE-87E2-42C1-9D43-C67FDF3C6E5C

Q33696003-F32514EE-1E60-4B76-9934-FFE881C6D44C

Q33696003-F6B0CF5F-CA6F-44CE-B22F-740277D7608E

P577

Q33696003-A67A43FF-6FEF-439B-9FA8-4272399A5482

P5875

Q33696003-743CD2B0-0BB3-4463-A85E-7E37243CA712

P698

Q33696003-9D80DB2C-A6DA-4A9A-AE73-44C4765476FC

P932

Q33696003-2EF1730B-49A8-4FDB-8ECE-7CE81333E087

P356

HAEMATOL.2013.103218

P1433

P1476

The predictive role of interim ...... the Deauville five-point scale

@en

P2093

Alberto Biggi

http://www.w3.org/2001/XMLSchema#string

Alessandro Pulsoni

http://www.w3.org/2001/XMLSchema#string

Andrea Gallamini

http://www.w3.org/2001/XMLSchema#string

Annika Loft

http://www.w3.org/2001/XMLSchema#string

Chiara Rusconi

http://www.w3.org/2001/XMLSchema#string

Eldad J Dann

http://www.w3.org/2001/XMLSchema#string

Flavia Salvi

http://www.w3.org/2001/XMLSchema#string

George N Mikhaeel

http://www.w3.org/2001/XMLSchema#string

Jan M Zaucha

http://www.w3.org/2001/XMLSchema#string

John F Seymour

http://www.w3.org/2001/XMLSchema#string

P2860

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Evaluation of survival data and two new rank order statistics arising in its consideration.

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

The role of FDG-PET scans in patients with lymphoma.

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

P304

1107-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2013.103218

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Simonetta Viviani

Stéphane Chauvie

Sally Barrington

Stefano Luminari

René-Olivier Casasnovas

Martin Hutchings

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261034313

http://www.w3.org/2001/XMLSchema#string

P698

24658820

http://www.w3.org/2001/XMLSchema#string

P932

4040916

http://www.w3.org/2001/XMLSchema#string